Kong et al. found a correlation between a lower number of circulating EPCs and lower cognitive function [31], whereas a study by Stellos et al. indicated that the number of circulating CD34+/CD133+ progenitor cells was significantly inversely correlated with AD patients’ cognitive function. Here, CD34 is linked to Alzheimer disease.